Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Stock

Oklo stock soar near new all-time high: here’s why analysts call it a ‘good pick’

admin by admin
August 5, 2025
in Stock
0
Oklo stock soar near new all-time high: here’s why analysts call it a ‘good pick’
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Oklo stock (OKLO: NYSE) surged to a new intraday high on Tuesday, trading at $82.39 at press time and pushing the company’s market cap to roughly $11.7 billion.

The jump reflects growing excitement around Oklo’s clean nuclear energy technology and its expanding network of industry partnerships.

The stock has had an explosive run, up, nearly 770% over the past year. In 2025 alone, it’s more than tripled, with gains of over 215% year-to-date.

Much of that momentum has come from increased confidence in Oklo’s next-gen reactor tech and its potential to shake up the energy sector.

Earlier this year, shares were trading in the mid-$50 range before this latest leg higher.

Oklo stock: What’s behind the rally?

A big part of it is progress on its Aurora reactor project, the company’s first shot at a commercial small modular nuclear plant.

Regulators at the US Nuclear Regulatory Commission have started to give the go-ahead on early-stage approvals, which helps speed things up and gives investors more confidence that this project is actually moving forward.

Then there’s the Liberty Energy deal. Oklo’s teaming up with them to pair its nuclear tech with Liberty’s natural gas infrastructure.

The idea is to create reliable, low-carbon power for industrial customers that can’t afford any downtime. For investors, it’s a sign that Oklo isn’t just about hype; it’s finding real partners and real markets.

Oklo also brought Kiewit Nuclear Solutions on board to head up construction for the Aurora plant. Pre-construction work is expected to kick off later this year, with the company aiming to have the plant up and running by late 2027 or early 2028.

If things stay on track, Oklo could be among the first to bring next-gen nuclear power online, right as demand for clean, steady energy continues to climb.

Good time to buy?

Wall Street is starting to catch on to Oklo’s momentum. A handful of analysts have bumped up their price targets, betting the company’s bigger reactor plans and long runway for growth could pay off in a big way.

Citi, for one, hiked its target from $30 to $68 last month, a clear sign it sees room for the stock to keep climbing as Oklo breaks into new markets.

That said, not everyone is charging in without caution. Some market watchers have flagged the stock’s sharp run-up and rich valuation as potential red flags. Still, the overall mood remains bullish.

With progress stacking up from clearing regulatory hurdles to locking in major partnerships, Oklo’s looking more and more like a company that could actually pull it off. If things stay on track, it might just become a serious player in clean energy over the next decade.

The broader analyst consensus backs the bullish sentiment. Out of roughly eight reports, the stock holds a strong buy rating, with a median price target hovering around $78-$80.

It’s a clear signal that Wall Street sees long-term promise in Oklo’s play for a bigger role in the future of nuclear energy.

The post Oklo stock soar near new all-time high: here’s why analysts call it a ‘good pick’ appeared first on Invezz


Previous Post

Three big reasons why Navitas Semiconductor stock is not a buy on post-earnings decline

Next Post

Yum Brands shares plunge 3% after Q2 earnings miss

Next Post
Yum Brands shares plunge 3% after Q2 earnings miss

Yum Brands shares plunge 3% after Q2 earnings miss

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

February 17, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock pops as big pharma giant delivers post-COVID comeback

0
From tariffs to DOGE, what companies are saying about the impact of MAGA policies

From tariffs to DOGE, what companies are saying about the impact of MAGA policies

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock pops as big pharma giant delivers post-COVID comeback

August 5, 2025
US stocks extends gains on Palantir Surge even with tariff concerns

US stocks extends gains on Palantir Surge even with tariff concerns

August 5, 2025
Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

August 5, 2025
Yum Brands shares plunge 3% after Q2 earnings miss

Yum Brands shares plunge 3% after Q2 earnings miss

August 5, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Pfizer stock pops as big pharma giant delivers post-COVID comeback

    Pfizer stock pops as big pharma giant delivers post-COVID comeback

    August 5, 2025
    US stocks extends gains on Palantir Surge even with tariff concerns

    US stocks extends gains on Palantir Surge even with tariff concerns

    August 5, 2025
    Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

    Novo Nordisk stock downgraded as Trump teases 250% pharma tariffs

    August 5, 2025
    Yum Brands shares plunge 3% after Q2 earnings miss

    Yum Brands shares plunge 3% after Q2 earnings miss

    August 5, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved